[go: up one dir, main page]

WO1986000014A1 - Topical compositions - Google Patents

Topical compositions Download PDF

Info

Publication number
WO1986000014A1
WO1986000014A1 PCT/US1985/001066 US8501066W WO8600014A1 WO 1986000014 A1 WO1986000014 A1 WO 1986000014A1 US 8501066 W US8501066 W US 8501066W WO 8600014 A1 WO8600014 A1 WO 8600014A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
urea
skin
amount
absorbing agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1985/001066
Other languages
French (fr)
Inventor
Murray Weiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO1986000014A1 publication Critical patent/WO1986000014A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/445Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Definitions

  • This invention relates to topical compositions for the prevention and/or reduction of skin damage caused by ultraviolet radiation.
  • this invention relates to the prevention and/or reduction of skin damage caused by reactive chemical substances generated in the skin by ultraviolet radiation.
  • the present invention provides a topical urea compo ⁇ sition, for prevention of skin damage due to ultraviolet radiation.
  • urea Since urea has no ultraviolet light absorbing pro ⁇ perties in the skin damaging light wave lengths of 290 to 400 mm, it is not a sunscreen agent. Its skin protective properties are as a neutralizer of damaging active chemical entities. Urea moderates the effects of nitrate reduction products, thus preventing skin damage following ultraviolet radiation.
  • concentration of urea which may be used in the topical compositions is from about 0.1% to about 40%, preferably from about 1% to about 20% based on the weight of the composition.
  • urea may be combined with known UV absorbing sun screen agents such as Padimato 0 (2-ethylhexyl-p-dimethyl amino- benzoate), Oxybenzone (2-hydroxy-4-methoxy benzophenone) and paraaminobenzoic acid (PABA) in topical compositions.
  • UV absorbing agents such as Padimato 0 (2-ethylhexyl-p-dimethyl amino- benzoate), Oxybenzone (2-hydroxy-4-methoxy benzophenone) and paraaminobenzoic acid (PABA)
  • This combination of UV absorbing agents and urea free radical neutralizer provides a superior skin protecting agent to that of the prior art.
  • the UV absorbing agent may be present in the topical composition from about 1% to about 10% by weight of the composition.
  • compositions of this invention are preferably applied to the skin in the form of conven- tional alcoholic lotions, liquid emulsions, creams, transparent gels, or aerosol sprays.
  • topical cream compositions A, B, C, D and E
  • topical cream compositions A, B, C, D and E
  • Carbopol 934 0. 1 0. 1 0. 1 0. 1 0. 1 0. 1 0. 1 0. 1 0. 1 (Polyacrylic acid)
  • compositions A, C and E provided a significant degree of protection against acute sunburn damage in hairless mouse skin as compared with placebo compositions.
  • SK-1 hairless mice observations were made of erythema responses under blinded conditions. There were striking differences in H and E stained tissue sections taken from the reaction sites.
  • the skin damage in placebo treated sites was two to three times greater than the urea composition treated sites, based upon thickness of the epidermis, the number of sunburn cells noted, and the dermal inflammatory changes.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

Topical compositions of urea, useful for the prevention and/or reduction of skin damage caused by ultraviolet radiation.

Description

TOPICAL COMPOSITIONS
This invention relates to topical compositions for the prevention and/or reduction of skin damage caused by ultraviolet radiation. In particular this invention relates to the prevention and/or reduction of skin damage caused by reactive chemical substances generated in the skin by ultraviolet radiation.
The health promoting qualities of sunlight have been recognized throughout history. However, in recent years, medical professionals and the lay public both have become awre of the skin diseases and degenerative processes that occur from prolonged and excessive exposure to ultra¬ violet (UV) radiation. Depending on skin types, even modest exposure can be damaging and dangerous. The mechanisms by which ultraviolet radiation exerts its adverse effects on the skin are not fully understood. They are believed to involve absorption of light energy by skin tissue components to produce very reactive substances such as free radicals. In particular, they involve the production in the skin tissue of nitroso, nitrite, and other mediators of undesired skin changes in sensitive individuals. The potential of nitrites to react with and damage tissue is well recognized. Recent experiments in vitro and in vivo have shown the contribution of nitrites to structual alteration of integumental (skin) structures.
Prior art topical compositions-for the prevention of UV induced skin damage-are essentially sunscreens in that they absorb light particularly in the ultraviolet wave lengths associated with skin damage. Even with the broad spectrum of sunscreen preparations available, ranging from modest to essentially complete UV blockage, serious problems of sun damaged skin persist. These sunscreens are not effective in reducing the formation of free radical substances such as nitrate reduction products in the skin tissue from UV light that does reach the skin. Furthermore, they do not hve any effect on the damaging interactions in the skin tissue caused by the free radicals produced. The present invention provides a topical urea compo¬ sition, for prevention of skin damage due to ultraviolet radiation.
Since urea has no ultraviolet light absorbing pro¬ perties in the skin damaging light wave lengths of 290 to 400 mm, it is not a sunscreen agent. Its skin protective properties are as a neutralizer of damaging active chemical entities. Urea moderates the effects of nitrate reduction products, thus preventing skin damage following ultraviolet radiation. The concentration of urea which may be used in the topical compositions is from about 0.1% to about 40%, preferably from about 1% to about 20% based on the weight of the composition.
It is a further embodiment of this invention to use chemical analogs of urea which have functional urea substitutions, in the topical compositons.
In a preferred embodiment of this invention urea may be combined with known UV absorbing sun screen agents such as Padimato 0 (2-ethylhexyl-p-dimethyl amino- benzoate), Oxybenzone (2-hydroxy-4-methoxy benzophenone) and paraaminobenzoic acid (PABA) in topical compositions. This combination of UV absorbing agents and urea free radical neutralizer, provides a superior skin protecting agent to that of the prior art. The UV absorbing agent may be present in the topical composition from about 1% to about 10% by weight of the composition.
The topical compositions of this invention are preferably applied to the skin in the form of conven- tional alcoholic lotions, liquid emulsions, creams, transparent gels, or aerosol sprays. EXAMPLE
The following ingredients were blended to form topical cream compositions (A, B, C, D and E) using conventional methods.
Percent w/w
Ingredients A B C D E
Mineral Oil 5-20 5-20 5-20 5-20 5-20 Isopropyl Myristate 0-10 0-10 0-10 0-10 0-10
Acetylated Lanolin 0- 10 0- 10 0-10 0-10 0-10 Alcohol
Cetyl Alcohol 1-10 1-10 1-10 1-10 1-10
Glycerol Mono- stearate 1-10 1-10 1-10 1-10 1-10
Tween 80 0-5 0-5 0-5 0-5 0-5
Methyl Paraffin 0.5 0. 5 0.5 0.5 0.5
Propyl Paraffin 0.2 0.2 0.2 0.2 0.2
Carbopol 934 0. 1 0. 1 0. 1 0. 1 0. 1 (Polyacrylic acid)
Sodium Hydroxide 0-0.1 0-0.1 0-0.1 0-0.1 0-0.1
Propyleneglyco1 0-5 0-5 0-5 0-5 0- 5
Urea 15 15 15
Padimate 0 - 1.4-8 1.4-8 - - (2-ethylhexyl-p-di- methyl amino- benzoate)
Oxybenzone __ _. _. 2-6 2-6
(2-Hydroxy-4-Methoxy Benzophenone)
Water q.s. q.s. q.s. q.s. q.s.
Total 100 100 100 100 100 In a study of ultraviolet light induced acute and chronic actinic damage, it was found that the urea compositions of this invention (e.g., compositions A, C and E) provided a significant degree of protection against acute sunburn damage in hairless mouse skin as compared with placebo compositions. Using SK-1 hairless mice, observations were made of erythema responses under blinded conditions. There were striking differences in H and E stained tissue sections taken from the reaction sites. The skin damage in placebo treated sites was two to three times greater than the urea composition treated sites, based upon thickness of the epidermis, the number of sunburn cells noted, and the dermal inflammatory changes.

Claims

WHAT IS CLAIMED IS:
1. A method for the prevention and/or reduction of skin damage caused by ultraviolet rdiation which comprises topically applying a composition of a therapeutically effective amount of urea in a pharmaceutically acceptable carrier to the skin of an individual in need of such skin treatment.
2. The method according to claim 1 wherein the amount of urea is from about 0.1 to about 40 percent based on the weight of the composition.
3. The method according to claim 2 wherein the amount of urea is from 1 to about 20 percent.
4. The method according to claim 1 wherein an ultraviolet radiation absorbing agent is present in the composition.
5. The method according to claim 4 wherein the ultraviolet radiation absorbing agent is 2-ethyl- hexyl-p-dimethyl aminobenzoate, 2-hydroxy-4-methoxy benzophenoue, or para-aminobenzoic acid.
6. The method according to claim 5 wherein the amount of ultraviolet absorbing agent is from about 1 to about 10 percent based on the weight of the composition.
7. A composition for the prevention and/or reduction of skin damage caused by ultraviolet radiation which comprises a therapeutically effective amount of urea and a therapeutically effective amount of an ultraviolet radiation absorbing agent.
8. The composition according to claim 7 wherein the ultraviolet radiation absorbing agent is 2-ethylhexyl-p- dimethyl aminobenzoate, 2-hydroxy-4-methoxy benzophenone, or para-aminobenzoic acid.
9. The composition according to claim 7 wherein the amount of urea is from about 0.1 to about 40 percent, and the ultraviolet radiation absorbing agent is from about 1 to about 10 percent, based on the weight of the composition.
10. The composition according to claim 7 wherein the amount of urea is from about 1 to about 20 percent.
11. The composition according to claim 8 wherein the amount of ultraviolet absorbing agent is from about 1-10 percent based on the weight of the composition.
PCT/US1985/001066 1984-06-11 1985-06-10 Topical compositions Ceased WO1986000014A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61900784A 1984-06-11 1984-06-11
US619,007 1984-06-11

Publications (1)

Publication Number Publication Date
WO1986000014A1 true WO1986000014A1 (en) 1986-01-03

Family

ID=24480056

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1985/001066 Ceased WO1986000014A1 (en) 1984-06-11 1985-06-10 Topical compositions

Country Status (3)

Country Link
EP (1) EP0182881A1 (en)
AU (1) AU4430685A (en)
WO (1) WO1986000014A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066726A (en) * 1990-04-23 1991-11-19 Shell Oil Company Process for melt grafting epoxy compounds to polymers
US5463291A (en) * 1993-12-23 1995-10-31 Carroll; Lewis Cyclotron and associated magnet coil and coil fabricating process
EP0688559A1 (en) * 1995-07-07 1995-12-27 Shiseido Company Limited Skin anti-ageing composition
US5837735A (en) * 1994-10-05 1998-11-17 Helsinn Healthcare S.A. Antiinflammatory agent for external use
EP2153815A1 (en) * 2008-08-05 2010-02-17 Isdin S.A. Use of urea containing compositions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1767165A1 (en) * 1968-04-06 1971-09-09 Joos Bernhard External product to prevent irritation, inflammation and sensitization
DE2706782A1 (en) * 1976-02-18 1977-09-01 Scherico Ltd SUN PROTECTION
DE2703185A1 (en) * 1977-01-27 1978-08-10 Henkel Kgaa Cosmetics contg. hydroxyalkyl-urea derivs. - useful as skin moisture regulators

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1767165A1 (en) * 1968-04-06 1971-09-09 Joos Bernhard External product to prevent irritation, inflammation and sensitization
DE2706782A1 (en) * 1976-02-18 1977-09-01 Scherico Ltd SUN PROTECTION
DE2703185A1 (en) * 1977-01-27 1978-08-10 Henkel Kgaa Cosmetics contg. hydroxyalkyl-urea derivs. - useful as skin moisture regulators

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Handbook of Nonprescription Drugs, issued 1977, American Pharmaceutical Association, see pages 280 to 287, 234 to 328 and 336-338 *
The Principles and Practice of Modern Cosmetics, issued March 1963, Vol. 2 R.G. HARRY, see pages 520 to 523 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066726A (en) * 1990-04-23 1991-11-19 Shell Oil Company Process for melt grafting epoxy compounds to polymers
US5463291A (en) * 1993-12-23 1995-10-31 Carroll; Lewis Cyclotron and associated magnet coil and coil fabricating process
US5837735A (en) * 1994-10-05 1998-11-17 Helsinn Healthcare S.A. Antiinflammatory agent for external use
EP0688559A1 (en) * 1995-07-07 1995-12-27 Shiseido Company Limited Skin anti-ageing composition
US5747049A (en) * 1995-07-07 1998-05-05 Shiseido Company, Ltd. Cosmetic composition
US6077520A (en) * 1995-07-07 2000-06-20 Shiseido Company, Ltd. Cosmetic composition
EP2153815A1 (en) * 2008-08-05 2010-02-17 Isdin S.A. Use of urea containing compositions

Also Published As

Publication number Publication date
AU4430685A (en) 1986-01-10
EP0182881A1 (en) 1986-06-04

Similar Documents

Publication Publication Date Title
US4806344A (en) Sun protectant composition and method
US5788954A (en) Hydrating skin care and sunscreen composition containing dibenzoylmethane derivative, E.G., parsol 1789, and C12, C16, C18 branched chain hydroxybenzoate and/or C12, C16, branched chain benzoate stabilizers/solubilizers
US4906457A (en) Compositions and methods for reducing the risk of sunlight and ultraviolet induced skin cancer
CA2015867C (en) Skin composition
JPH08259421A (en) Cosmetic or dermatologically active compound formulations of cinnamic acid derivatives and flavone glycosides
GB2206282A (en) Topical composition for protecting against solar radiation
WO2001091695A2 (en) The use of resveratrol as sunscreen
AU2001281792A1 (en) The use of resveratrol as sunscreen
EP0843996B1 (en) Sun protecting cosmetic compositions comprising derivatives of dibenzoylmethane and of benzophenone
US4959205A (en) Composition and method for treatment of dermal inflammation
US5256403A (en) Composition and method for protecting the skin from UV-rays
WO1986000014A1 (en) Topical compositions
CN116059127B (en) Natural sun-screening composition and preparation method and application thereof
US6630175B1 (en) Method of reducing eye irritation
WO1991007166A1 (en) Compositions and methods for reducing the risk of sunlight and ultraviolet induced skin cancer
US4734434A (en) Method for the treatment of pruritus and composition for the use therein
KR20150041938A (en) Mixture for protecting skin and Cosmetic composition comprising thereof for protecting skin from ultraviolet rays
BR0000627A (en) Cosmetic composition for topical use, use of the composition and cosmetic treatment process
TW200500059A (en) Cosmetic and/or pharmaceutical compositions for the cure and prevention of irritation, inflammation and cutaneous erythema
EP2928460B1 (en) Methods for preventing and treating inflammatory skin conditions
JP2008515766A (en) Topical composition for preventing and treating skin damage caused by exposure to UV light
US6485714B1 (en) Use of salicylic acid for regulating hyperpigmented spots
WO2001070190A2 (en) Cosmetic compositions
JP3432033B2 (en) Photoaging agent and skin cosmetic containing the same
KR20230135528A (en) Cosmetic compositions comprising astaxanthin, epidermal growth factor and mixed extracts of natural product as effective components

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU JP

Designated state(s): AU JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE

Designated state(s): AT BE CH DE FR GB IT LU NL SE